BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37726932)

  • 21.
    Baek EB; Hwang YH; Park S; Hong EJ; Won YS; Kwun HJ
    Res Rep Urol; 2022; 14():313-326. PubMed ID: 36187165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uvaria rufa Blume attenuates benign prostatic hyperplasia via inhibiting 5α-reductase and enhancing antioxidant status.
    Buncharoen W; Saenphet K; Saenphet S; Thitaram C
    J Ethnopharmacol; 2016 Dec; 194():483-494. PubMed ID: 27732901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of
    Choi YJ; Kim EK; Fan M; Tang Y; Hwang YJ; Sung SH
    Int J Environ Res Public Health; 2019 Oct; 16(19):. PubMed ID: 31591335
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
    Paterniti I; Campolo M; Cordaro M; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
    Inflamm Res; 2018 Jul; 67(7):617-626. PubMed ID: 29679313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of finasteride and laser-irradiated silver nanoparticles on testicular function and histology in testosterone induced benign prostatic hyperplasia in rats.
    Marghani BH; Ezz MA; Ateya AI; Fehaid A; Saleh RM; Rezk S
    Life Sci; 2023 Jul; 324():121747. PubMed ID: 37137466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the Serum Prostatic Biomarkers During the Treatment of Benign Prostatic Hyperplasia with a 5alpha-reductase Inhibitor: Finasteride.
    Golchin-Rad K; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Derakhshandeh N; Abbaszadeh-Hasiri M
    Top Companion Anim Med; 2020 Mar; 38():100405. PubMed ID: 32115076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2.
    Zhao Y; Zhang Y; Li Y; Yang M; Yuan J; Cao Y; Xu L; Ma X; Lin S; An J; Wang S
    Eur J Pharmacol; 2021 Oct; 908():174334. PubMed ID: 34265299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chinese Skullcap (Scutellaria baicalensis Georgi) inhibits inflammation and proliferation on benign prostatic hyperplasia in rats.
    Jin BR; Chung KS; Kim HJ; An HJ
    J Ethnopharmacol; 2019 May; 235():481-488. PubMed ID: 30708034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2.
    Raafat M; Kamel AA; Shehata AH; Ahmed AF; Bayoumi AMA; Moussa RA; Abourehab MAS; El-Daly M
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
    Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
    Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astaxantin and Isoflavones Inhibit Benign Prostatic Hyperplasia in Rats by Reducing Oxidative Stress and Normalizing Ca/Mg Balance.
    Semenov AL; Gubareva EA; Ermakova ED; Dorofeeva AA; Tumanyan IA; Radetskaya EA; Yurova MN; Aboushanab SA; Kanwugu ON; Fedoros EI; Panchenko AV
    Plants (Basel); 2021 Dec; 10(12):. PubMed ID: 34961206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heat-Killed and Live
    Choi YJ; Fan M; Tang Y; Iwasa M; Han KI; Lee H; Hwang JY; Lee B; Kim EK
    J Microbiol Biotechnol; 2021 Aug; 31(8):1134-1143. PubMed ID: 34226410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway.
    Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY
    Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of
    Choi YJ; Fan M; Wedamulla NE; Tang Y; Bae SM; Hwang JY; Kim EK
    Food Funct; 2022 Oct; 13(19):10235-10247. PubMed ID: 36124918
    [No Abstract]   [Full Text] [Related]  

  • 36. [Efficacy of Kangshuailing Gao on benign prostatic hyperplasia in rats].
    Li R; Jia DY; Li Z; Xu DR; Luo SY
    Zhonghua Nan Ke Xue; 2018 Aug; 24(8):729-734. PubMed ID: 30173434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hexane fraction of Annona muricata (Sour sop) seed ameliorates testosterone-induced benign prostatic hyperplasia in rats.
    Adaramoye OA; Oladipo TD; Akanni OO; Abiola OJ
    Biomed Pharmacother; 2019 Mar; 111():403-413. PubMed ID: 30594779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Phellius linteus water extract on benign prostatic hyperplasia.
    Kim YN; Kim MS; Chun SS; Choi JH
    Nutr Res Pract; 2013 Jun; 7(3):172-7. PubMed ID: 23766877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective role of diosmin against testosterone propionate-induced prostatic hyperplasia in Wistar rats: Plausible role of oxidative stress and inflammation.
    Vafa A; Afzal SM; Barnwal P; Rashid S; Shahid A; Alpashree ; Islam J; Sultana S
    Hum Exp Toxicol; 2020 Sep; 39(9):1133-1146. PubMed ID: 31797688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Melandrium firmum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats.
    Lee MY; Shin IS; Seo CS; Lee NH; Ha HK; Son JK; Shin HK
    Asian J Androl; 2012 Mar; 14(2):320-4. PubMed ID: 22231294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.